Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Gamma Knife Surgery, Linear Accelerator, Cyberknife, TomoTherapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Stem Cell Growth Factors, Erythropoiesis-Stimulating Agents (ESAs), Darbepoetin, Epoetin, Methoxy polyethylene glycol (PEG) epoetin-beta | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Stem Cell Growth Factor, Romiplostim (e.g., Nplate) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Stationary Ultrasonic Diathermy Devices | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Spinal Unloading Devices For Treatment Of Low Back Pain (Orthotrac Pneumatic Vest) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Spinal Manipulation Under General Anesthesia | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Spinal Decompression Therapy (Internal Disc Decompression Therapy, Spinal Distraction Therapy) Using Motorized and/or Computerized Traction | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Spinal Cord Neurostimulation for Treatment of Intractable Pain | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sphenopalatine Ganglion and Occipital Nerve Injections for Headache | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Spesolimab-sbzo (e.g., Spevigo) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Soft Tissue Substitutes, Orthobiologic Implant | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sodium Thiosulfate (e.g., Pedmark) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sodium Iodide I 131 Oncologic Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Diagnosis of Obstructive Sleep Apnea Syndrome (e.g., polysomnography, sleep study) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sleep Apnea, Minimally Invasive Surgical Treatment | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sleep Apnea Ventilation Support and Respiratory Assist Devices | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Skin and Soft Tissue Substitutes, Bio-Engineered Products (Including Prosthetic Material) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Site of Care or Site of Service Review | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sipuleucel-T (e.g., Provenge) for the Treatment of Prostate Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sinus Spacers, Stents, and Implants, following Endoscopic Sinus Surgery | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Siltuximab (e.g., Sylvant) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Serum Antibodies for Diagnosis of Inflammatory Bowel Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sensory Integration Therapy and Auditory Integration Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Semi-Implantable and Fully Implantable Middle Ear Hearing Aid for Moderate to Severe Sensorineural Hearing Loss | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Self-Administered Medication | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Secukinumab (e.g., Cosentyx) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Screening for Vertebral Fracture with Dual X-ray Absorptiometry (DEXA) or Biomechanical Computed Tomography | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Scleral Contact Lens, Gas Permeable | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Scintimammography and Gamma Imaging of the Breast and Axilla | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Safety Beds | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sacral Nerve Stimulation for the Treatment of Neurogenic Bladder Secondary To Spinal Cord Injury | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sacral Nerve Neuromodulation/Stimulation for Non-Neurogenic Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sacituzumab govitecan-hziy (e.g., Trodelvy) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Vitamin B12 and Methylmalonic Acid Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Venous and Arterial Thrombosis Risk Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Urine Culture Testing for Bacteria | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Thyroid Disease Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Serum Testing for Evidence of Mild Traumatic Brain Injury | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Prenatal Screening (Nongenetic) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Pediatric Preventive Screening | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Onychomycosis Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Diagnostic Testing of Iron Homeostasis and Metabolism | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_General Inflammation Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_In Vitro Chemoresistance and Chemosensitivity Assays | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Helicobacter pylori Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Gamma-glutamyl Transferase Testing in Adults | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Folate Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | RTM_Flow Cytometry | New policy |